The patient described in this study carrying a pathogenic variant in BMPR2 was included in the CHEST study [31] and therefore diagnosed to suffer from CTEPH by an international expert panel. The gene discussed is BMPR2; the disease is chronic thromboembolic pulmonary hypertension.